Skip to main content

MJFF Publications

876 - 900 of 7616 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • RESTRICTED
    Title: Biomarkers and non-motor symptoms as a function of motor symptom asymmetry in early Parkinson's disease
    Journal Name: Neuropsychologia
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108419
    Citation Count: 6
  • RESTRICTED
    Title: Brain network characteristics and cognitive performance in motor subtypes of Parkinson's disease: A resting state fMRI study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.027
    Best OA location URL:
    Citation Count: 2
  • RESTRICTED
    Title: Collaboration and knowledge integration for successful brain therapeutics – lessons learned from the pandemic
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.049755
    Citation Count: 0
  • RESTRICTED
    Title: Comparison of manual and automated measures of walking speed: Distance and pace matter
    Journal Name: Experimental Gerontology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.exger.2022.111987
    Citation Count: 2
  • RESTRICTED
    Title: Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach
    Journal Name: Neuropeptides
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.npep.2022.102283
    Best OA location URL:
    Citation Count: 6
  • RESTRICTED
    Title: Effective R2 relaxation rate, derived from dual-contrast fast-spin-echo MRI, enables detection of hemisphere differences in iron level and dopamine function in Parkinson’s disease and healthy individuals
    Journal Name: Journal of Neuroscience Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jneumeth.2022.109708
    Citation Count: 5
  • RESTRICTED
    Title: Epidemiology meets toxicogenomics: Mining toxicologic evidence in support of an untargeted analysis of pesticides exposure and Parkinson’s disease
    Journal Name: Environment International
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.envint.2022.107613
    Citation Count: 5
  • RESTRICTED
    Title: Functional Interaction Between α-Synuclein and Nurr1 in Dopaminergic Neurons
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2022.10.011
    Best OA location URL:
    Citation Count: 1
  • RESTRICTED
    Title: Impact of the COVID-19 Pandemic on the Behavioral Health of People With Intellectual and Developmental Disabilities
    Journal Name: Psychiatric Services
    Publisher: American Psychiatric Association Publishing
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1176/appi.ps.202100524
    Best OA location URL:
    Citation Count: 10
  • RESTRICTED
    Title: Impairment of amacrine starburst cells and their synaptic contacts with dopaminergic cells could explain motion perception disturbances in Parkinson's disease
    Journal Name: Acta Ophthalmologica
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/j.1755-3768.2022.0786
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer’s disease
    Journal Name: Cell Stem Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.stem.2022.11.010
    Citation Count: 44
  • RESTRICTED
    Title: Machine learning‐based prediction of cognitive outcomes in de novo Parkinson's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/alz.067067
    Citation Count: 0
  • RESTRICTED
    Title: Major advances in Parkinson's disease over the past two decades and future research directions
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00448-3
    Best OA location URL:
    Citation Count: 4
  • RESTRICTED
    Title: Molecular heterogeneity in the substantia nigra: A roadmap for understanding PD motor pathophysiology
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2022.105925
    Citation Count: 9
  • RESTRICTED
    Title: Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.002
    Citation Count: 6
  • RESTRICTED
    Title: Nano drug delivery systems for antisense oligonucleotides (ASO) therapeutics
    Journal Name: Journal of Controlled Release
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jconrel.2022.10.050
    Best OA location URL:
    Citation Count: 22
  • RESTRICTED
    Title: Non-REM sleep with hypertonia in Parkinsonian Spectrum Disorders: A pilot investigation
    Journal Name: Sleep Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.sleep.2022.09.025
    Citation Count: 5
  • RESTRICTED
    Title: Orchestration of selective autophagy by cargo receptors
    Journal Name: Current Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.cub.2022.11.002
    Citation Count: 32
  • RESTRICTED
    Title: P5B-ATPases in the mammalian polyamine transport system and their role in disease
    Journal Name: Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: publisher-specific-oa, publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.bbamcr.2022.119354
    Citation Count: 11
  • RESTRICTED
    Title: Parkinson’s disease drug hunters think outside the α-synuclein box
    Journal Name: Nature Biotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41587-022-01610-w
    Best OA location URL:
    Citation Count: 1
  • RESTRICTED
    Title: Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s disease
    Journal Name: Biomedicine & Pharmacotherapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.biopha.2022.113908
    Citation Count: 3
  • RESTRICTED
    Title: Pompe disease treated before birth
    Journal Name: Nature Biotechnology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41587-022-01621-7
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Precision medicine for Parkinson’s disease: The subtyping challenge
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.1064057
    Citation Count: 2
  • RESTRICTED
    Title: REM sleep behavior and olfactory dysfunction: Enhancing the utility and translation of animal models in the search for precision medicines for Parkinson's disease
    Journal Name: Neuroscience & Biobehavioral Reviews
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neubiorev.2022.104897
    Best OA location URL:
    Citation Count: 1
  • RESTRICTED
    Title: Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.019
    Best OA location URL:
    Citation Count: 7
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.